Immunology

Stanford Immunology is an internationally recognized center of excellence in immunological research, education, and clinical translation. Founded in 1988, the Ph.D. Program in Immunology is one of the 14 prestigious Home Programs within the Stanford Biosciences. The program is built on a long-standing tradition of collaboration, bringing together basic scientists, computational biologists, and clinical researchers to decode the complexities of the immune system in health and disease.

The program's research and training efforts span the entire spectrum of immunological inquiry, from fundamental molecular and cellular biology to "bench-to-bedside" clinical translation. Leveraging state-of-the-art facilities across the School of Medicine, the Department of Biology, and the Veterans Affairs Palo Alto Health Care System, Stanford Immunology is dedicated to developing the next generation of scientific leaders who will drive innovation in immunobiology, immunotherapy, and global health.

Academic and Training Pathways

The PhD Program in Immunology currently supports over 60 graduate students and a vibrant community of postdoctoral scholars. The program provides an integrated, interdisciplinary curriculum spanning basic, computational, and clinical immunology:

• Doctor of Philosophy (Ph.D.) in Immunology: A research-intensive doctoral pathway offering two specialized, cutting-edge tracks of study:

  • Molecular, Cellular, and Translational Immunology (MCTI) Track: Focuses on the classical and physical mechanisms of immune cell development, signaling, antigen presentation, and the translation of these principles into novel immunotherapies.

  • Computational and Systems Immunology (CSI) Track (Founded in 2011): One of the first tracks of its kind in the nation, this program integrates big data, high-throughput technologies, machine learning, and computational modeling to analyze the immune system at a systems-wide level.

• Scholarly Community and Events: Trainees actively participate in student-led journal clubs, weekly seminar series, and the hallmark Annual Stanford Immunology Scientific Conference, which serves as a premier forum for presenting new discoveries and fostering collaborative research.

Research Frontiers and Clinical Translation

Stanford Immunology faculty are pioneers in their respective fields, developing next-generation tools and therapeutics to treat cancer, infectious diseases, and chronic inflammatory conditions:

• Cancer Immunotherapy and Car-T Cells: Advancing the development of cellular therapies, immune checkpoint inhibitors, and cancer vaccines to target and eliminate solid tumors and hematological malignancies.

• Autoimmunity and Chronic Inflammation: Deciphering the breakdown of immune tolerance in diseases such as rheumatoid arthritis, multiple sclerosis, and type 1 diabetes to design targeted, non-immunosuppressive therapies.

• Host-Pathogen Interactions and Vaccinology: Investigating the immune system's response to viral, bacterial, and parasitic infections, and designing novel vaccine platforms to elicit long-lasting protective immunity.

• Transplantation Immunology: Enhancing organ transplant survival by developing innovative methods to prevent graft rejection and induce immune tolerance without the need for lifelong systemic immunosuppression.

• Systems and Single-Cell Immunological Profiling: Utilizing state-of-the-art mass cytometry (CyTOF), single-cell RNA sequencing, and multiplexed imaging to map the human immune system in unprecedented detail.